Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | CTSD | P07339 | 7/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.40 |
| ▸ | GUSB | P08236 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25171984 | 0.86 | KDM4E (0.42) | KDM4EALDH1A1HSD17B10HPGDHTT | |
| SCHEMBL25167039 | 0.82 | KDM4E (0.39) | KDM4EALDH1A1HSD17B10HPGDHTT | |
| SCHEMBL23673271 | 0.81 | KDM4E (0.44) | KDM4EALDH1A1HSD17B10HPGDHTT | |
| SCHEMBL222054 | 0.76 | AKT1 (0.47) | KDM4ENPC1MAPT | |
| SCHEMBL5952313 | 0.74 | KDM4E (0.43) | KDM4EALDH1A1HSD17B10HPGDHTT | |
| SCHEMBL4061092 | 0.73 | MEN1 (0.54) | KDM4EALDH1A1HSD17B10HPGDL3MBTL1 | |
| SCHEMBL2655223 | 0.73 | SMN1; SMN2 (0.52) | KDM4EALDH1A1HTTSMN1; SMN2NPC1 | |
| SCHEMBL30374176 | 0.73 | KDM4E (0.46) | KDM4EALDH1A1HSD17B10HPGDHTT | |
| SCHEMBL25417739 | 0.73 | KDM4E (0.46) | KDM4EALDH1A1HSD17B10HPGDHTT | |
| SCHEMBL25120662 | 0.73 | KDM4E (0.39) | KDM4EALDH1A1HSD17B10HPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11778895-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-03 | — | — | US | disclosed |
| US-11778895-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-03 | — | — | US | disclosed |
| US-11778895-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-03 | — | — | US | disclosed |
| US-20210234099-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-07-29 | — | — | US | disclosed |
| US-20210234099-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210234099-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | EPCAM, PIEZO1, OR10J3 | KDM4E 2434/4885ALDH1A1 865/4885HSD17B10 3916/4885 |
| US-11778895-B2 | Organic electroluminescent materials and devices | EPCAM, PIEZO1, OR10J3 | KDM4E 2434/4885ALDH1A1 865/4885HSD17B10 3916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.